PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
CACG vs. ARKG
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility

Correlation

The correlation between CACG and ARKG is 0.65, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.


-0.50.00.51.00.7

Performance

CACG vs. ARKG - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in ClearBridge All Cap Growth ESG ETF (CACG) and ARK Genomic Revolution Multi-Sector ETF (ARKG). The values are adjusted to include any dividend payments, if applicable.

-5.00%0.00%5.00%10.00%JulyAugustSeptemberOctoberNovemberDecember0
-3.74%
CACG
ARKG

Key characteristics

Returns By Period


CACG

YTD

N/A

1M

N/A

6M

N/A

1Y

N/A

5Y*

N/A

10Y*

N/A

ARKG

YTD

-27.83%

1M

1.37%

6M

-2.83%

1Y

-26.09%

5Y*

-7.08%

10Y*

1.96%

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


CACG vs. ARKG - Expense Ratio Comparison

CACG has a 0.53% expense ratio, which is lower than ARKG's 0.75% expense ratio.


ARKG
ARK Genomic Revolution Multi-Sector ETF
Expense ratio chart for ARKG: current value at 0.75% compared with the broader market ranging from 0.00% to 2.12%.0.50%1.00%1.50%2.00%0.75%
Expense ratio chart for CACG: current value at 0.53% compared with the broader market ranging from 0.00% to 2.12%.0.50%1.00%1.50%2.00%0.53%

Risk-Adjusted Performance

CACG vs. ARKG - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for ClearBridge All Cap Growth ESG ETF (CACG) and ARK Genomic Revolution Multi-Sector ETF (ARKG). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for CACG, currently valued at 1.43, compared to the broader market0.002.004.001.43-0.59
The chart of Sortino ratio for CACG, currently valued at 2.20, compared to the broader market-2.000.002.004.006.008.0010.002.20-0.66
The chart of Omega ratio for CACG, currently valued at 1.39, compared to the broader market0.501.001.502.002.503.001.390.93
The chart of Calmar ratio for CACG, currently valued at 2.05, compared to the broader market0.005.0010.0015.002.05-0.30
The chart of Martin ratio for CACG, currently valued at 9.20, compared to the broader market0.0020.0040.0060.0080.00100.009.20-1.00
CACG
ARKG


Rolling 12-month Sharpe Ratio-1.000.001.002.003.00JulyAugustSeptemberOctoberNovemberDecember
1.43
-0.59
CACG
ARKG

Dividends

CACG vs. ARKG - Dividend Comparison

Neither CACG nor ARKG has paid dividends to shareholders.


TTM2023202220212020201920182017
CACG
ClearBridge All Cap Growth ESG ETF
0.34%0.34%0.34%2.92%0.47%0.64%0.68%0.24%
ARKG
ARK Genomic Revolution Multi-Sector ETF
0.00%0.00%0.00%0.62%0.85%3.14%1.94%1.34%

Drawdowns

CACG vs. ARKG - Drawdown Comparison


-80.00%-60.00%-40.00%-20.00%0.00%JulyAugustSeptemberOctoberNovemberDecember0
-78.81%
CACG
ARKG

Volatility

CACG vs. ARKG - Volatility Comparison

The current volatility for ClearBridge All Cap Growth ESG ETF (CACG) is 0.00%, while ARK Genomic Revolution Multi-Sector ETF (ARKG) has a volatility of 14.47%. This indicates that CACG experiences smaller price fluctuations and is considered to be less risky than ARKG based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


0.00%5.00%10.00%15.00%JulyAugustSeptemberOctoberNovemberDecember0
14.47%
CACG
ARKG
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2024 PortfoliosLab